Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase

Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase

Objective: Donepezil, an inhibitor of acetylcholinesterase (AChE) targeting the brain, is a common medication for Alzheimer's disease. Interestingly, a recent clinical study found that administration of this agent is associated with lower risk of hip fracture independently of falling, suggestin...

Full description

Bibliographic Details
Main Authors: Tsuyoshi Sato, Yuichiro Enoki, Yasushi Sakamoto, Kazuhiro Yokota, Masahiko Okubo, Masahito Matsumoto, Naoki Hayashi, Michihiko Usui, Shoichiro Kokabu, Toshihide Mimura, Yoshihiko Nakazato, Nobuo Araki, Toru Fukuda, Yasushi Okazaki, Tatsuo Suda, Shu Takeda, Tetsuya Yoda
Format: Article
Language:English
Published: Elsevier 2015-09-01
Series:Heliyon
Subjects:
Acetylcholinesterase
Osteoclast
Donepezil
Alzheimer's disease
Differentiation
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844015302620

Internet

http://www.sciencedirect.com/science/article/pii/S2405844015302620

Similar Items